Sector portfolio · Private equity · China
IDG Capital's Biotech portfolio
IDG Capital has backed 19 Biotech startups in rounds we track, $1.6B between them, shown by the stage each has reached. The best-funded is Brainco.
Funding by segment
- Series C and later$528M6
- Series B$402M6
- Stage not reported$555M4
- Series A$106M3
Where they are based
- China12$1.0B
- United States4$461M
- Japan1$87M
- South Korea1$22M
China
United States
Japan
South KoreaFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M8
- $50M to $250M10
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 19 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- China12
- United States4
- Japan1
- South Korea1
Startups by country, 4 countries in all.
Segment by segment
Series C and later
6 startups · $528M raised
- CBCreative BiosciencesCreative Biosciences is a biomedical technology company.China$132M
BiotheusBiotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.China$115M
HiFiBiOHiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.United States$105M- TTeligeneTeligene is a drug discovery company edicating to developing innovative small-molecule drugs.China$93M
Sciwind BiosciencesSciwind Biosciences is a drug research and development company for metabolic diseases.China$70M- YBYuce Biological TechnologyYuce Biological Technology is a biotechnology developer which focuses on cancer diagnosis through gene detection.China$14M
Series B
6 startups · $402M raised
Avistone PharmaceuticalsAvistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.China$141M
D3 BioD3 Bio is a clinical-stage biotechnology company based in Wuxi, China, founded in 2020.China$108M
EdiGeneEdiGene is a biotechnology company that develops genome editing technologies.Japan$87M
OrigimedOrigiMed provides molecular diagnostic information for cancer patient.China$29M
ColorTech BioColorTech Bio researches and develops precision molecular diagnostic equipment.China$24M- LBLayerwave BioLayerwave Bio is a developer of IVD diagnostic instrument reagents and biomedical scientific research instruments.-$14M
Stage not reported
4 startups · $555M raised
BrainCoBrain Co.United States$292M
MedbanksMedbanks develops customized medical service and health care based on self-built medical expert network and drugstore network, proChina$201M
Spot BiosystemsSpot Biosystems is building the next generation of non-viral gene therapy with an extracellular vesicle (EV) delivery platform.United States$40M
Doosan Mobility InnovationDoosan Mobility Innovation (DMI) is a South Korean company and a subsidiary of the Doosan Group, established in 2016.South Korea$22M
Series A
3 startups · $106M raised
Neukio BiotherapeuticsNeukio Biotherapeutics focuses on development of next generation allogenic cell therapies via the iPSC-CAR-NK axis, through internChina$50MDinfectomeDinfectome researches and develops molecular detection technology.China$31M
- PPaige.AIUnited States$25M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names IDG Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like IDG Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.